Clinical trial
Guiding Evidence Based Therapy Using Biomarker Intensified Treatment
NCT01685840
Study timeline
Study start (unknown)2012-12-01Date precision: month
Registry last updated2017-12-12
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Heart Failureunresolved
Interventions
Usual CareOTHER
Sponsors & collaborators
Duke Universitylead sponsor
Mapped research locations
The BronxNew York, United States3BostonMassachusetts, United States2PhiladelphiaPennsylvania, United States2VancouverBritish Columbia, Canada2DallasTexas, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1AtlantaGeorgia, United States1TorontoOntario, Canada1ClevelandOhio, United States1PittsburghPennsylvania, United States1CincinnatiOhio, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01685840 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.